Your browser doesn't support javascript.
loading
Blocking the CXCL1-CXCR2 axis enhances the effects of doxorubicin in HCC by remodelling the tumour microenvironment via the NF-κB/IL-1ß/CXCL1 signalling pathway.
Zhao, Huiyong; Wei, Sheng; Zhou, Dachen; Liu, Yongfan; Guo, Zicheng; Fang, Chuibao; Pang, Xiaoxi; Li, Fei; Hou, Hui; Cui, Xiao.
Afiliação
  • Zhao H; Department of General Surgery, The Second Hospital of Anhui Medical University, Hefei, China.
  • Wei S; Department of General Surgery, The Second Hospital of Anhui Medical University, Hefei, China.
  • Zhou D; Department of General Surgery, The Second Hospital of Anhui Medical University, Hefei, China.
  • Liu Y; Department of General Surgery, The Second Hospital of Anhui Medical University, Hefei, China.
  • Guo Z; Department of General Surgery, The Second Hospital of Anhui Medical University, Hefei, China.
  • Fang C; Department of General Surgery, The Second Hospital of Anhui Medical University, Hefei, China.
  • Pang X; Department of Nuclear Medicine, The Second Hospital of Anhui Medical University, Hefei, China.
  • Li F; Department of Nuclear Medicine, The Second Hospital of Anhui Medical University, Hefei, China.
  • Hou H; Department of General Surgery, The Second Hospital of Anhui Medical University, Hefei, China. Hui0402@hotmail.com.
  • Cui X; Department of General Surgery, The Second Hospital of Anhui Medical University, Hefei, China. cx_2077@bjmu.edu.cn.
Cell Death Discov ; 9(1): 120, 2023 Apr 10.
Article em En | MEDLINE | ID: mdl-37037815

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cell Death Discov Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cell Death Discov Ano de publicação: 2023 Tipo de documento: Article